NCT00115830View on ClinicalTrials.gov

Rho Kinase in Patients With Atherosclerosis

PHASE3CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2007

Conditions

Atherosclerosis

Interventions

DRUG

Atorvastatin

DRUG

Rosuvastatin

Trial Locations (1)

02115

Brigham and Womens Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER

NCT00115830 - Rho Kinase in Patients With Atherosclerosis | Biotech Hunter | Biotech Hunter